Urology
Volume 70, Issue 6, Supplement 1 , Pages S16-S21 , December 2007

“Male Lumpectomy”: Focal Therapy for Prostate Cancer Using Cryoablation

  • Gary Onik

      Affiliations

    • Corresponding Author InformationReprint requests: Gary Onik, MD, Department of Radiology and Urology, Division of Surgical Imaging, Center for Surgical Advancement, Celebration Health/Florida Hospital, 400 Celebration Place, Celebration, Florida 34747.
    • Dr. Onik holds stock in Endocare, Inc.
    • ,
  • David Vaughan

      Affiliations

    • Dr. Vaughan has no financial arrangement or affiliation with a corporate organization or a manufacturer of a product discussed in this supplement.
    • ,
  • Richard Lotenfoe

      Affiliations

    • Dr. Lotenfoe has no financial arrangement or affiliation with a corporate organization or a manufacturer of a product discussed in this supplement.
    • ,
  • Martin Dineen

      Affiliations

    • Dr. Dineen has no financial arrangement or affiliation with a corporate organization or a manufacturer of a product discussed in this supplement.
    • ,
  • Jeff Brady

      Affiliations

    • Dr. Brady has no financial arrangement or affiliation with a corporate organization or a manufacturer of a product discussed in this supplement.

References 

  1. Santiago RJ, Wu L, Harris E, et al. Fifteen-year results of breast-conserving surgery and definitive irradiation for stage I and II breast carcinoma: the University of Pennsylvania experience. Int J Radiat Oncol Biol Phys. 2005;58:233–240
  2. Messing EM, Thompson I. Follow-up of conservatively managed prostate cancer: watchful waiting and primary hormonal therapy. Urol Clin North Am. 2003;30:687–702
  3. Onik GM, Cohen JK, Reyes GD, et al. Transrectal ultrasound–guided percutaneous radical cryosurgical ablation of the prostate. Cancer. 1993;72:1291–1299
  4. Djavan B, Susani M, Bursa B, et al. Predictability and significance of multi-focal prostate cancer in the radical prostatectomy specimen. Techn Urol. 1999;5:139–142
  5. Villers A, McNeal JE, Freiha FS, et al. Multiple cancers in the prostate: morphologic features of clinically recognized vs. incidental tumors. Cancer. 1992;70:2312–2318
  6. Rukstalis DB, Goldknopf JL, Crowley EM, et al. Prostate cryoablation: a scientific rationale for future modifications. Urology. 2002;60:19–25
  7. Noguchi M, Stamey TA, McNeal JE, et al. Prognostic factors for multifocal prostate cancer in radical prostatectomy specimens: lack of significance of secondary cancers. J Urol. 2003;170:459–463
  8. Levine MA, Ittman M, Melamed J. Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer. J Urol. 1998;159:471–475
  9. Graefen M, Hammerer P, Michl U, et al. Incidence of positive surgical margins after biopsy-selected nerve sparing radical prostatectomy. Urology. 1998;51:437–442
  10. Crawford ED, Wilson SS, Torkko KC, et al. Clinical staging of prostate cancer: a computer-simulated study of transperineal prostate biopsy. BJU Int. 2005;96:999–1004
  11. Onik GM. 3D global mapping biopsies: a more efficacious method of determining the extent of prostate cancer. 2006;Presented at the Consensus Conference on Focal Therapy of Prostate Cancer; February 24, Orlando, Florida
  12. Donnelly BJ, Salikan JC, Ernst DS, et al. Prospective trial of cryosurgical ablation of the prostate: five-year results. Urology. 2002;60:645–649
  13. Bahn DK, Lee F, Bandalament R, et al. Seven-year outcomes in the primary treatment of prostate cancer. Urology. 2002;60:3–11
  14. Katz A, Rewcastle JC. The current and potential role of cryoablation as a primary treatment for prostate cancer. Curr Oncol Rep. 2003;5:231–238
  15. Gould RS. Total cryoablation of the prostate versus standard cryoablation versus radical prostatectomy: comparison of early results and the role of trans-urethral resection in cryoablation. J Urol. 1999;162:1653–1657
  16. Onik G, Narayan P, Vaughan D, et al. Focal nerve sparing cryoablation for the treatment of primary prostate cancer: a new approach to preserving potency. Urology. 2002;60:109–114
  17. Wong WS, Chinn DO, Chinn M, et al. Cryoablation as a treatment for prostate carcinoma: results and complications. Cancer. 1997;79:963–974
  18. Catalona WJ, Basler JW. Return of erections and urinary continence following nerve sparing radical retropubic prostatectomy. J Urol. 1993;150:905–907
  19. Talcott JA, Reiker P, Propert KJ, et al. Patient reported impotence and incontinence after nerve-sparing radical prostatectomy. J Natl Cancer Inst. 1989;16:1117–1123
  20. Sanchez-Ortiz RF, Broderick GA, Rovner ES, et al. Erectile function and quality of life after interstitial radiation therapy for prostate cancer. Int J Impot Res. 2000;12(Suppl 3):S18–S24
  21. Zelefsky MJ, Hollister T, Raben A, et al. Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localized prostate cancer. Int J Radiat Oncol Biol Phys. 2000;47:1261–1266
  22. O’Sullivan DC, Barrett DM, Colby TV, et al. Effect of external beam radiation therapy on prostatic carcinoma DNA content as measured by static image cytometry. Eur Urol. 1992;21:235–239

PII: S0090-4295(07)00663-2

doi: 10.1016/j.urology.2007.06.001

Urology
Volume 70, Issue 6, Supplement 1 , Pages S16-S21 , December 2007

Article Tools

* Image Usage & Resolution